Panda Biotech Announces Landmark Equity Partnership With Southern Ute Growth Fund Aka-Ag, LLC
Panda Biotech announces a landmark equity partnership deal between the Panda High Plains Hemp Gin™ (PHPHG) project and the Southern Ute Indian Tribe Growth Fund (Growth Fund). The Growth Fund is owned by the Southern Ute Indian Tribe, a federally recognized tribe. The strategic alliance was inked with Aka-Ag, LLC, a Growth Fund subsidiary.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230405005286/en/
Panda Biotech's Panda High Plains Hemp Gin Facility in Wichita Falls, TX (Photo: Business Wire)
The investment marks a significant advancement toward PHPHG’s much-anticipated Q4 2023 launch. Located in Wichita Falls, Texas, PHPHG is on track to become the largest hemp decortication center in the United States and among the world’s largest industrial hemp processing facilities.
President Dixie Carter says of the deal, “Panda Biotech could not have selected a better equity partner for our first project, the Panda High Plains Hemp Gin. The Southern Ute Indian Tribe and its subsidiaries bring numerous strategic opportunities to what is anticipated to be a successful, long-term partnership.”
The Southern Ute Indian Tribe is the first Indian tribe in the nation to achieve a ‘AAA’ credit rating, earned through years of steady governance and successful and prudent business transactions. The Growth Fund, the business division of the Southern Ute Indian Tribe, aims to support eco-minded business investment opportunities through Aka. As hemp provides a proven, more sustainable ecological option than other textile fibers, the Growth Fund’s Aka-Ag division shares Panda Biotech’s vision for PHPHG and the revolutionary potential of natural hemp fiber.
Growth Fund Executive Director Shane Seibel added, “the Growth Fund is honored to partner with Panda Biotech on the PHPHG Project. The Tribe and Panda have had decades of success in various business endeavors. We view the PHPHG investment as a complementary and strategic partnership that will align with our company values and result in a business providing sustainable solutions for the future.”
Scientifically proven to sequester substantial amounts of carbon dioxide, industrial hemp requires significantly less water, herbicides, fungicides, and pesticides to grow than most crops used in textile manufacturing. The textile industry has taken notice of PHPHG’s charge with industry leaders, including numerous global brands and top spinning mills around the world, reaching out regarding potential partnerships with Panda.
To date, approximately 95 percent of the necessary hemp processing equipment has been manufactured, most of which has been delivered to the 500,000-square-foot facility in Wichita Falls. PHPHG is expected to be operational in the 4th quarter of this year.
The PHPHG facility will process only U.S.-grown hemp straw. Panda is contracting with producers for the 2023 growing season and has seed available for farmers. The available seed genetic is proven to grow successfully in the region around Wichita Falls. For further information, including Grower Inquiries, please visit www.pandabiotech.com.
ABOUT PANDA BIOTECH
Based in Dallas, Texas, privately-held Panda Biotech, LLC is a first-mover in the emerging U.S. industrial hemp fiber and hurd industry. Panda Biotech’s executive leadership has extensive experience developing, financing, constructing, and operating large-scale infrastructure facilities in clean energy. They have developed 22 projects representing approximately $12 billion in invested capital. The company is currently developing large-scale industrial hemp gin facilities. Panda’s first facility, the Panda High Plains Hemp Gin™ LLC (PHPHG) located in Wichita Falls, TX, will be operational in Q4 2023. It will be the largest hemp processing and mechanical cottonization facility in the western hemisphere. For more information, please visit www.pandabiotech.com and @pandabiotech on Instagram, Twitter, or LinkedIn.
ABOUT SOUTHERN UTE GROWTH FUND
Based in Colorado on the Southern Ute Indian Reservation, the Southern Ute Growth Fund maintains the Southern Ute Indian Tribe’s thriving and diverse business portfolio. The Growth Fund exists to grow economic prosperity for the Tribe and its members by responsibly conducting the Tribe’s businesses and developing new growth opportunities prudently. The Southern Ute Growth Fund comprises the Red Willow Production Company, Red Cedar Gathering Company, GF Properties Group, GF Ventures, GF Private Equity, Aka Energy Group, and Aka-Ag. The Southern Ute Tribe was awarded a ‘AAA’ general-obligation bond rating, the first Native American Tribe to earn the rating.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230405005286/en/
Contact information
Media (only)
Beth Gebhard
615-336-0194
bethgebhard@gmail.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Decent Cybersecurity to Showcase Post-Quantum Solutions at DSEI Japan 202516.5.2025 10:49:00 EEST | Press release
Decent Cybersecurity announces its participation at DSEI Japan 2025 as the only Slovak cybersecurity company exhibiting at this premier defense event in Makuhari Messe, Chiba (May 21-23, 2025). The company will showcase its advanced post-quantum security solutions for aerospace, defense, and space sectors, including SpaceShield STM, DroneCrypt UTM, and QuantumProof Protocol. "The Indo-Pacific region represents a critical frontier for post-quantum cybersecurity innovation as quantum computing advances threaten traditional encryption," said Matej Michalko, Founder, Chairman and CEO of Decent Cybersecurity. "Our participation demonstrates our commitment to offering Japanese defense and space agencies access to European-certified, quantum-resistant security solutions that protect critical infrastructure against emerging threats." As a holder of NATO, EU, and national security clearances at the "Secret" level, Decent Cybersecurity brings unique post-quantum security credentials to the Japan
LTIMindtree, Eurobank and Fairfax Digital Services Collaborate to Build Digital Innovation Hub in Cyprus16.5.2025 10:00:00 EEST | Press release
LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital solutions company, has announced the opening of its Digital Innovation Hub at the Research and Innovation Hub of CYENS Center of Excellence. The LTIMindtree Digital Innovation Hub will enable ideation, co-creation and implementation of Advanced Digital Solutions for Eurobank, Fairfax and other EU customers and aligns with the strategic vision of the Cyprus Government to strengthen Cyprus’ role as a regional tech and innovation hub, triggering unique cross-border opportunities for tech collaborations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515054331/en/ Srini Rao EVP & Chief Business Officer- Europe, LTIMindtree | Mr. Nikodemos Damianou, Deputy Minister of Research and Innovation, Govt of Cyprus | Mr. Fokion Karavias, Group CEO, EUROBANK Group | Mr. Sanjay Tugnait, President & CEO, Fairfax Digital along with other esteemed client execu
ROYC Acts as the Structuring and Financial Technology Partner for Riverside for European Wealth Access Fund16.5.2025 09:30:00 EEST | Press release
ROYC, the leading provider of complete private markets operating systems, announces the structuring of a new access fund for Private Wealth launched in collaboration with The Riverside Company. The Riverside Company is a global private equity firm focused on investing in growing businesses valued at up to $400 million. Since its founding in 1988, Riverside has made more than 1,000 investments and today has over $12 billion in assets under management. The firm's international private equity and structured capital portfolios include more than 140 companies. The Riverside’s proven investment strategy of acquiring and developing high-potential European SMEs in resilient, growth-oriented sectors, including technology and software, healthcare, advanced manufacturing and consumer products. “This fund represents a unique opportunity for wealth investors to access value creation generally reserved for institutional investors,” says Karsten Langer, Managing Partner at Riverside Europe and contin
Rimini Street Announces Upcoming 2025 Investor Conference Schedule15.5.2025 23:51:00 EEST | Press release
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced that Michael L. Perica, chief financial officer, and Dean Pohl, vice president, treasurer and investor relations, will be presenting and meeting with investors one-on-one and in small group meetings at the following conferences: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515374696/en/ Rimini Street Announces Upcoming 2025 Investor Conference Schedule May 28, 2025: Craig-Hallum 22nd Annual Institutional Investor Conference, Minneapolis May 29, 2025: TD Cowen 53rd Annual TMT Conference, New York City Fireside Chat: 1:15 pm Eastern, webcast link June 24-26, 2025: Roth 15th Annual London Conference, London To schedule a meeting please contact your salesperson or Rimini Street Investor Relations at IR@rimin
Incyte Announces FDA Approval of Zynyz ® (retifanlimab-dlwr) Making it the First and Only Approved First-Line Treatment for Advanced Anal Cancer Patients in the United States15.5.2025 21:30:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Zynyz® (retifanlimab-dlwr), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal (SCAC). In addition, the FDA granted approval for Zynyz as a single agent for the treatment of adult patients with locally recurrent or with metastatic SCAC with disease progression on or intolerance to platinum-based chemotherapy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250508024371/en/ Zynyz logo "The FDA approval of Zynyz marks a pivotal moment, bringing effective combination and monotherapy treatment options to patients with advanced anal cancer after decades of limited innovation," said Hervé Hoppenot,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom